Encephalitis is a serious inflammatory disorder of the brain caused by viral, bacterial, fungal, parasitic, or autoimmune factors. It remains a significant global health concern due to its potential to cause severe neurological complications, long-term disability, and mortality. Early diagnosis, rapid intervention, and advances in molecular diagnostics, neuroimaging, antiviral therapies, and immunotherapy are improving patient outcomes. This track focuses on the latest research in the epidemiology, diagnosis, treatment, prevention, and management of encephalitis and other infectious neurological disorders.
Market Analysis: The global encephalitis diagnostics and therapeutics market is estimated to be valued at USD 23.2 billion in 2025 and is projected to reach approximately USD 36.5 billion by 2034, growing at a CAGR of 5.2% during the forecast period. Market growth is driven by the increasing incidence of viral encephalitis, rising vector-borne infections, advancements in molecular diagnostics and neuroimaging, and growing investments in antiviral drugs and immunotherapies. North America currently dominates the market owing to its advanced healthcare infrastructure, while the Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare expenditure, expanding diagnostic capabilities, and the high prevalence of encephalitis-causing pathogens such as Japanese encephalitis virus.
Share this page on your timeline
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance
Tags
Microbiology Conferences
Pathology Conferences
Vector-Borne Diseases Conferences
Public Health Conferences
Infection Conferences 2027 Asia
Virology Conferences
Infection Conferences 2027
Infection Conferences 2026
Infectious Disease Conferences
Infectious Disease Conferences 2026 Asia
Epidemiology Conferences
Infectious Diseases Conferences
Contagious Diseases Conferences